ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 288

$688K Total Retail Price of All Prescriptions

Rank: 28 out of 288

517 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,127 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 678 582 1 1
LEVOTHYROXINE SODIUM 530 430 2 2
HYDROCODONE-ACETAMINOPHEN 424 273 S3 3 7
OMEPRAZOLE 384 336 4 3
AMLODIPINE BESYLATE 359 317 5 6
LISINOPRIL 248 195 6 4
FUROSEMIDE 221 146 7 5
METFORMIN HCL 212 172 8 12
METOPROLOL SUCCINATE 206 179 9 15
GLIMEPIRIDE 183 149 10 32
WARFARIN SODIUM 173 166 11 9
CITALOPRAM HBR 161 143 12 18
PREDNISONE 158 144 13 30
POTASSIUM CHLORIDE 157 129 14 11
METOPROLOL TARTRATE 148 106 15 8
ALLOPURINOL 143 132 16 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 127 17 34
TAMSULOSIN HCL 133 118 18 24
ATENOLOL 132 126 19 10
GABAPENTIN 132 101 19 17
ZOLPIDEM TARTRATE 127 103 21 22
SERTRALINE HCL 117 95 22 25
FLUTICASONE PROPIONATE 116 102 23 41
FENOFIBRATE 109 103 24 61
ATORVASTATIN CALCIUM 109 99 24 14
CRESTOR 107 106 26 26
LOSARTAN-HYDROCHLOROTHIAZIDE 105 99 27 55
PRAVASTATIN SODIUM 104 87 28 21
DOXAZOSIN MESYLATE 97 87 29 78
HYDROCHLOROTHIAZIDE 96 74 30 13
BENAZEPRIL HCL 94 79 31 52
LOSARTAN POTASSIUM 90 90 32 16
TRAMADOL HCL 84 65 33 19
CYMBALTA 75 58 34 67
CLOPIDOGREL 74 68 35 47
AMLODIPINE BESYLATE-BENAZEPRIL 71 58 36 89
FLUOXETINE HCL 70 47 37 64
MORPHINE SULFATE ER 69 44 S2 38 131
MELOXICAM 69 48 38 44
CYCLOBENZAPRINE HCL 67 39 R 40 73
ANDROGEL 66 61 S3 41 319
PRAMIPEXOLE DIHYDROCHLORIDE 65 48 42 122
NABUMETONE 64 56 43 108
OXYCODONE HCL 64 35 S2 43 127
VESICARE 63 55 45 129
ADVAIR DISKUS 63 57 45 50
PANTOPRAZOLE SODIUM 62 32 47 42
CLONIDINE HCL 59 45 48 70
LYRICA 57 45 49 114
NEXIUM 54 25 50 43
FAMOTIDINE 52 52 51 68
FENTANYL 52 40 S2 51 57
SPIRIVA 51 46 53 48
TERAZOSIN HCL 50 50 54 85
OXYCONTIN 50 42 S2 54 182
GLYBURIDE 50 38 R 54 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.